Please use this identifier to cite or link to this item:
Title: Casticin-induced inhibition of cell growth and survival are mediated through the dual modulation of Akt/mTOR signaling cascade
Authors: Lee, J.H.
Kim, C.
Um, J.-Y.
Sethi, G. 
Ahn, K.S.
Keywords: Akt/mTOR
Issue Date: 2019
Publisher: MDPI AG
Citation: Lee, J.H., Kim, C., Um, J.-Y., Sethi, G., Ahn, K.S. (2019). Casticin-induced inhibition of cell growth and survival are mediated through the dual modulation of Akt/mTOR signaling cascade. Cancers 11 (2) : 254. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Abstract: The Akt/mTOR signaling cascade is a critical pathway involved in various physiological and pathological conditions, including regulation of cell proliferation, survival, invasion, and angiogenesis. In the present study, we investigated the anti-neoplastic effects of casticin (CTC), identified from the plant Vitex rotundifolia L., alone and/or in combination with BEZ-235, a dual Akt/mTOR inhibitor in human tumor cells. We found that CTC exerted a significant dose-dependent cytotoxicity and reduced cell proliferation in a variety of human tumor cells. Also, CTC effectively blocked the phosphorylation levels of Akt (Ser473) and mTOR (Ser2448) proteins as well as induced substantial apoptosis. Additionally treatment with CTC and BEZ-235 in conjunction resulted in a greater apoptotic effect than caused by either agent alone thus implicating the anti-neoplastic effects of this novel combination. Overall, the findings suggest that CTC can interfere with Akt/mTOR signaling cascade involved in tumorigenesis and can be used together with pharmacological agents targeting Akt/mTOR pathway. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.
Source Title: Cancers
ISSN: 20726694
DOI: 10.3390/cancers11020254
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3390_cancers11020254.pdf2.39 MBAdobe PDF



Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons